4.7 Letter

Long-term outcome of higher-risk MDS patients treated with azacitidine: an update of the GFM compassionate program cohort

Journal

BLOOD
Volume 119, Issue 25, Pages 6172-6173

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2012-04-422204

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available